LUNA BIOSCIENCE, INC.
Biotech · Private
Recombinant leptospiral Virulence Modifying (VM) protein-based vaccine against human leptospirosis
- Grants
- $1.5M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Leptospirosis Vaccine Development | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Leptospiral VM Protein Antigen Detection for Rapid Diagnosis of Leptospirosis | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Leptospirosis Vaccine Development | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Leptospiral VM Protein Antigen Detection for Rapid Diagnosis of Leptospirosis | $299,631 | |
| Federal grant | Department of Health and Human Services · Phase I · Antibody Detection for Diagnosis of Acute Leptospirosis | $300,435 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2734 | TRAVERSE BIOTECH II INC | — | — |
| 2735 | INCOMPUTABLE LLC | — | — |
| 2736 | HYDROGENE THERAPEUTICS INC | — | — |
| 2737 | LUNA BIOSCIENCE, INC. | — | — |
| 2738 | DFH Pharma, Inc | — | — |
| 2739 | MIXEDLCMEDIA LLC | — | — |
| 2740 | LUCEOME BIOTECHNOLOGIES, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- A Virulence Modifying Protein-based Recombinant Vaccine And Rapid Diagnostic Assay For Leptospiraapplication
- Virulence Modifying Protein-based Recombinant Vaccine And Rapid Diagnostic Assay For Leptospiraapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.